Oragenics Announces the Exercise of Warrants and a Management Change
Gury announced that Mister Stanley B. Stein, a recently appointed director, has general the role of interim CEO Head of the state until a permanent CEO can be appointed. Jeffrey Hillman, Dotti Delfino and David Gury endure the CSO, CFO and Chairman, respectively.
Finally, there keep been no changes with regards to other employees or to the scientific and elaborating crew which testament linger to duty under Dr. Hillman's direction. Approximately Oragenics: Oragenics, Inc. The Business has a symbol of products in discovery, preclinical and clinical development, with a concentration in the leading therapeutic sphere of infectious diseases.
Our core pipeline includes products and supporting platform technologies for benefit in the treatment and diagnosis of bacterial infections. These forward-looking statements are based on management's beliefs and assumptions and hookup currently available. The text "believe," "expect," "anticipate," "intend," "estimate," "project" and companion expressions that complete not relate solely to historical things spot forward-looking statements.
Investors should be cautious in relying on forward-looking statements since they are paragraph to a combo of risks, uncertainties, and other factors that could target actual results to differ materially from those expressed in any such forward-looking statements.
These factors include, on the other hand are not district to those locate forth in our most recently filed annual announcement on Configuration 10-KSB and quarterly report on Anatomy 10-QSB, and other factors detailed from age to future in filings with the Securities and Modify Commission.
We remarkably disclaim any contract to rejuvenate forward-looking statements. Contact: Oragenics, Inc.
Comments to this post not accepted.
